Related Experiment Videos
Pharmacokinetics of gentamicin in very low birth weight preterm infants
Insights
Two gentamicin dosing regimens (every 18 or 24 hours) were effective for low birth weight preterm infants with suspected infections. Gentamicin clearance correlated with gestational age, suggesting individualized dosing may be beneficial.
Area of Science:
- Neonatal pharmacology
- Pediatric infectious diseases
- Clinical pharmacokinetics
Background:
- Low birth weight preterm infants are vulnerable to infections.
- Gentamicin is a common antibiotic for treating neonatal infections.
- Optimizing gentamicin dosing is crucial to balance efficacy and toxicity.
Purpose of the Study:
- To compare the efficacy and safety of two gentamicin intramuscular dosing regimens in low birth weight preterm infants.
- To assess the relationship between gentamicin pharmacokinetics and gestational age.
Main Methods:
- Low birth weight preterm infants received gentamicin intramuscularly every 18 hours (2.5 mg/kg) or every 24 hours (3.0 mg/kg).
- Plasma gentamicin levels were monitored during dosage intervals over a 10-day period.
- Correlation between gentamicin body clearance and gestational age was analyzed.
Main Results:
- Both gentamicin dosing regimens achieved satisfactory plasma concentrations.
- No statistically significant differences in gentamicin levels were observed between the 18-hour and 24-hour regimens.
- Gentamicin body clearance showed a significant positive correlation with gestational age (r = 0.76, p < 0.01).
Conclusions:
- Both gentamicin regimens (every 18 or 24 hours) are clinically useful for low birth weight preterm infants.
- The 24-hour dosing interval may offer practical advantages in terms of compliance.
- Gestational age is a key factor influencing gentamicin clearance in this population.
Abstract:
Low birth weight preterm infants with suspected infection were administered gentamicin intramuscularly every 18 h (2.5 mg/kg) or 24 h (3.0 mg/kg). For both dosage regimens plasma gentamicin levels were monitored during a dosage interval on three separate occasions over a 10 day period. Both regimens gave satisfactory plasma concentrations and there was no important statistically significant difference between the two. The body clearance of gentamicin correlated with gestational age (r = 0.76, p less than 0.01). The results indicate either regimen may be useful in the clinical situation but from a practical standpoint administration every 24 h may be easier to comply with then every 18 h.